Table 3.

Indications and “off-label” use of infliximab (IFX) and adalimumab (ADL) [78,92].

IFX	ADL
Crohn’s disease Ulcerative colitis Pediatric Crohn’s disease Pediatric ulcerative colitis Rheumatoid arthritis Ankylosing spondylitis Psoriatic arthritis Psoriasis	Crohn’s disease Ulcerative colitis Pediatric Crohn’s disease Rheumatoid arthritis Juvenile idiopathic arthritis Polyarticular juvenile idiopathic arthritis Active enthesitis-related arthritis Psoriatic arthritis Plaque psoriasis Pediatric plaque psoriasis Axial spondyloarthritis Hidradenitis suppurativa Uveitis Pediatric uveitis Panuveitis
Behcet’s disease Pyoderma gangrenosum Hidradenitis suppurativa Graft versus host disease Sjogren’s syndrome Uveitis Kawasaki disease	Behcet’s disease Pyoderma gangrenosum Alopecia areata Pemphigus Sarcoidosis Wegener’s granulomatosis